Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder

NCT05558371 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05558371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05558371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2021
Completion date
February 15, 2027
Enrollment
1,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cdd, cdkl5, cdkl5 deficiency disorder